Your funds, side by side
The lines these funds hold in common, and the companies you own through them. Weights are the ones each document states, with no currency conversion.
- VanEck Biotech ETF VanEck ETF Trust · 24 lines · as of Mar 31, 2026 · 100.0 %
Add a second fund to see what the two hold in common.
The companies you hold through them
A company's weight in the portfolio is its weight inside each fund, times that fund's share of the portfolio. With no amounts given, the funds weigh the same.
| Holding | VanEck Biotech ETF |
|---|---|
| Gilead Sciences Inc | 14.63 % |
| Amgen Inc | 14.54 % |
| Vertex Pharmaceuticals Inc | 8.06 % |
| Regeneron Pharmaceuticals, Inc. | 7.51 % |
| Argenx SE | 5.28 % |
| Insmed Inc | 4.59 % |
| IQVIA Holdings Inc | 4.30 % |
| Alnylam Pharmaceuticals Inc | 4.11 % |
| Natera Inc | 3.98 % |
| United Therapeutics Corp | 3.81 % |
| Biogen Inc | 3.72 % |
| BEONE MEDICINES LTD | 3.25 % |
| Moderna Inc | 3.10 % |
| Revolution Medicines Inc | 2.86 % |
| Illumina Inc | 2.49 % |
| Incyte Corp | 2.25 % |
| BioNTech SE | 2.15 % |
| Neurocrine Biosciences Inc | 1.94 % |
| BioMarin Pharmaceutical Inc | 1.39 % |
| Bio-Techne Corp | 1.35 % |
| Charles River Laboratories International Inc | 1.28 % |
| ICON PLC | 1.27 % |
| QIAGEN NV | 1.15 % |
| Tempus AI Inc | 0.93 % |
1 funds, 24 lines read.